A peptide sequence from platelet factor 4 (CT-112) is effective in the treatment of type II collagen induced arthritis in mice

Journal of Rheumatology

Volumn 24, Issue 5, 1997, Pages 890-898

  Wooley, Paul H ^a,c   Schaefer, Caralee ^a   Whalen, Janey D ^a   Dutcher, Julie A ^a   Counts, David F ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Curative Technologies Inc

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

COLLAGEN INDUCED ARTHRITIS; CYTOKINES; INFLAMMATION; PEPTIDES; PLATELET FACTOR 4

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; THROMBOCYTE FACTOR 4;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL ADHESION; COLLAGEN DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TREATMENT PLANNING;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; ARTHRITIS, REACTIVE; CELL DIVISION; CELLS, CULTURED; COLLAGEN; CONCANAVALIN A; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED DBA; MITOGENS; PEPTIDE FRAGMENTS; PLATELET FACTOR 4; SPLEEN; TETRAZOLIUM SALTS; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031006265     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gengrinovitch S, Greenberg SM, Cohen T, et al: Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem 1995;270:15059-65.
2. Seguchi M, Nakajima S: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4. Ann Allergy Asthma Immunol 1995;74:255-7.
3. Taub D, Dastych J, Inamura N, et al: Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 1995;154:2393-402.
4. Gupta SK, Singh JP: Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J Cell Biol 1994;127:1121-7.
5. Tatakis DN: Human platelet factor 4 is a direct inhibitor of human osteoblast-like osteosarcoma cell growth. Biochem Biophys Res Commun 1992;187:287-93.
6. Yoshimitsu K, Wright KC, Wallace S, Charnsangavej C, Mavligit GM: Hepatic arterial infusion of recombinant platelet factor-4 suppresses metastases to the lungs from tumors implanted into the livers of rabbits. Cancer 1995;75:2435-41.
7. Daly TJ, LaRosa GJ, Dolich S, Maione TE, Cooper S, Broxmeyer HE: High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. J Biol Chem 1995;270:23282-92.
8. Gupta SK, Hassel T, Singh JP: A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci (USA) 1995;92:7799-803.
9. Darveau RP, Blake J, Seachord CL, et al: Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest 1992;90:447-55.
10. Talmadge JE, Kelsey LS, Brown GS, Counts DF: Anti-inflammatory activity of an orally active peptide sequence from PF-4 on acute inflammation and DTH. Inflammation Research 1995;44:(suppl 2) 44:199-200.
11. Wooley PH, Whalen JD, Dutcher JA, Counts DF: The influence of a peptide sequence from PF-4 (CT-112) on type II collagen-induced arthritis in mice. Inflamm Res 1994;(suppl 2)44:S125-6.
12. Wooley PH: Collagen-induced arthritis in the mouse. Methods Enzymol 1988;162:361-73.
13. Wooley PH, Luthra HS, Stuart JM, David CS: Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154:688-700.
14. Oliver SJ, Banquerigo ML, Brahn E: Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell Immunol 1994;157:291-9.
15. Nemoto K, Mae T, Abe F, Takeuchi T: Successful treatment with a novel immunosuppressive agent, deoxyspergualin, in type II collagen-induced arthritis in mice. Ann NY Acad Sci 1993;685:148-54.
16. Wolos JA, Logan DE, Bowlin TL: Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collagen-induced arthritis. Cell Immunol 1990;125:498-507.
17. Takagishi K, Kaibara N, Hotokebuchi T, Arita C, Morinaga M, Arai K: Effects of cyclosporin on collagen induced arthritis in mice. Ann Rheum Dis 1986;45:339-44.
18. Williams RO, Mason LJ, Feldmann M, Maini RN: Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 1994;91:2762-6.
19. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ: Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993;261:1328-30.
20. Wooley PH, Banerjee S: Immunotherapy of collagen-induced arthritis with anti-Ia and anti-IL-2R antibodies. In: Kresina T, ed. Monoclonal Antibodies, Cytokines, and Arthritis. New York: Marcel Dekker, 1991:269-87.
21. Wooley PH, Cingel B: Staphylococcal enterotoxin B increases the severity of type II collagen induced arthritis in mice. Ann Rheum Dis 1995;54:298-304.
22. Wooley PH, Dutcher J, Widmer MB, Gillis S: Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 1993;151:6602-7.
23. Phadke K, Fouts RL, Parrish JE, Butler LD: Evaluation of the effects of various anti-arthritic drugs on type II collagen-induced mouse arthritis model. Immunopharm 1985;10:51-60.
24. McCune WJ, Trentham DE, David JR: Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis. Arthritis Rheum 1980;23:932-6.
25. Stuart JM, Myers LK, Townes AS, Kang AH: Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum 1981;24:790-4.
26. Cannon GW, McCall S, Cole BC, Griffiths MM, Radov LA, Ward JR: Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice. Agents Actions 1990;29:315-23.
27. Helfgott SM, Bazin H, Dessein A, Trentham DE: Suppressive effects of anti-mu serum on the development of collagen arthritis in rats. Clin Immunol Immunopathol 1984;31:403-11.
28. Brahn E, Trentham DE: Effect of antithymocyte serum on collagen arthritis in rats: Evidence that T cells are involved in its pathogenesis. Cell Immunol 1984;86:421-8.
29. Ranges GE, Sriram S, Cooper SM: Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 1985;162:1105-10.
30. Phadke K, Carlson DG, Gitter BD, Butler LD: Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models. J Immunol 1986;136:4085-91.
31. Hayashida K, Ochi T, Fujimoto M, et al: Bone marrow changes in adjuvant-induced and collagen-induced arthritis. Interleukin-1 and interleukin-6 activity and abnormal myelopoiesis. Arthritis Rheum 1992;35:241-5.
32. Killar LM, Dunn CJ: Interleukin-1 potentiates the development of collagen-induced arthritis in mice. Clin Science 1989;76:535-8.
33. Hom JT, Bendele AM, Carlson DG: In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol 1988;141:834-41.
34. Wooley PH, Whalen JD, Chapman DL, Berger AE, Richard KA, Aspar DG: The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 1993;36:1305-14.
35. Cooper WO, Fava RA, Gates CA, Cremer MA, Townes AS: Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol 1992;89:244-50.
36. Thorbecke CJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA: Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992;89:7375-9.
37. Brahn E, Peacock DJ, Banquerigo ML, Liu DY: Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis. Lymphokine & Cytokine Research 1992;11:253-6.
38. Williams RO, Feldmann M, Maini RN: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992;89:9784-8.
39. Peacock DJ, Banquerigo ML, Brahn E: Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 1992;175:1135-8.